Endothelin-1 plasma levels in cluster headache. 2002

R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
Division of Internal Medicine II, Department of Internal Medicine, University of Genoa, Italy.

OBJECTIVE A role for endothelin-1, a potent vasoconstrictor peptide, in some cerebrovascular diseases has been proposed. To obtain preliminary data about peripheral concentrations of endothelin-1 in acute cluster headache, we measured the plasma endothelin-1 secretory pattern in 10 men with cluster during and independent of a headache attack. METHODS We collected blood samples for plasma endothelin-1 determinations at 0, 15, 30, 45, 60, 90, and 120 minutes during a cluster attack and closely monitored blood pressures. We repeated the same sampling during an asymptomatic period. RESULTS The mean values of plasma endothelin-1 (before a cluster headache, 3.3 +/- 0.3 pg/mL) significantly increased (F = 2.578, P < .05) during an attack, reaching their peak at 30 minutes (5.0 +/- 0.5 pg/mL, P < .05). We found no significant variations in mean arterial pressure. CONCLUSIONS Endothelin-1 may play a role in the pathophysiology of cluster attacks. The increase in plasma observed during cluster attacks may be linked to alterations in systemic hemodynamics and vascular tone.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003027 Cluster Headache A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) Ciliary Neuralgia,Headache, Cluster,Histamine Cephalgia,Horton Syndrome,Neuralgic Migraine,Atypical Cluster Headache,Chronic Cluster Headache,Cluster Headache Syndrome,Episodic Cluster Headache,Horton's Syndrome,Atypical Cluster Headaches,Cephalgia, Histamine,Cephalgias, Histamine,Chronic Cluster Headaches,Ciliary Neuralgias,Cluster Headache Syndromes,Cluster Headache, Atypical,Cluster Headache, Chronic,Cluster Headache, Episodic,Cluster Headaches,Cluster Headaches, Atypical,Cluster Headaches, Chronic,Cluster Headaches, Episodic,Episodic Cluster Headaches,Headache Syndrome, Cluster,Headache Syndromes, Cluster,Headache, Atypical Cluster,Headache, Chronic Cluster,Headache, Episodic Cluster,Headaches, Atypical Cluster,Headaches, Chronic Cluster,Headaches, Cluster,Headaches, Episodic Cluster,Histamine Cephalgias,Hortons Syndrome,Migraine, Neuralgic,Migraines, Neuralgic,Neuralgia, Ciliary,Neuralgias, Ciliary,Neuralgic Migraines,Syndrome, Cluster Headache,Syndrome, Horton,Syndrome, Horton's,Syndromes, Cluster Headache
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D019333 Endothelin-2 A 21-amino acid peptide produced predominantly within the kidney and intestine, with smaller amounts produced in the myocardium, placenta, and uterus, but the cells of origin are not clear. Endothelin-2 has no unique physiologic functions, as compared with endothelin-1. (N Eng J Med 1995;333(6):356-63) Endothelin 2

Related Publications

R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
March 1983, Cephalalgia : an international journal of headache,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
March 1976, Headache,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
July 1982, Headache,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
May 2012, American journal of therapeutics,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
January 2007, Journal of intensive care medicine,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
January 1996, Cardiology,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
January 2000, International journal of clinical & laboratory research,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
January 2013, Advances in clinical and experimental medicine : official organ Wroclaw Medical University,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
January 1997, Clinical rheumatology,
R Franceschini, and G L Tenconi, and M Leandri, and F Zoppoli, and A Gonella, and S Staltari, and T Barreca
August 1993, Acta endocrinologica,
Copied contents to your clipboard!